芝商所:銅期權持倉量創歷史新高
芝商所宣佈,銅期權持倉量已接連數次創下紀錄,最終於2023年1月18日實現137,574份合約,創歷史新高。月初至今,其公司銅期貨和期權產品組合的日均交易量爲131,466份合約,較2022年全年日均交易量增長42%。月初至今,銅期權日均交易量爲12,513份合約,比去年增長410%。
芝商所金屬產品全球主管Jin Chang表示,隨着市場參與者應對持續的經濟衰退風險和中國放寬新冠疫情管控措施帶來的影響,他們越來越多地使用芝商所的銅期權產品來應對潛在的價格波動。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.